Synonyms: compound 4 [WO2019218987A1] [2] | D-0316 | D0316 | Surmana®
befotertinib is an approved drug (China NMPA (2023))
Compound class:
Synthetic organic
Comment: Befotertinib (D-0316) is an third generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that was developed as a treatment for non-small cell lung cancer (NSCLC) [2].
|
|
For advanced searching click here to open chemical structure editor
Similar Ligands ![]() |
|||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
|